Nantahala Capital Management, LLC 13D and 13G filings for Soleno Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:32 pm Purchase |
2024-12-31 | 13G | Soleno Therapeutics, Inc. SLNO |
Nantahala Capital Management, LLC | 4,349,435 9.990% |
398,148 (+10.08%) |
Filing |
| 2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Soleno Therapeutics, Inc. SLNO |
Nantahala Capital Management, LLC | 3,951,287 9.990% |
3,951,287 (New Position) |
Filing |